XML 26 R16.htm IDEA: XBRL DOCUMENT v3.10.0.1
Note 11 - Stock-based Compensation
9 Months Ended
Oct. 31, 2018
Notes to Financial Statements  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]
11.
STOCK-BASED COMPENSATION
 
The Company’s equity awards consist of RSUs and SARs. For a description of the Company’s stock-based compensation plans, see Note
5
“Stock-Based Compensation” in Notes to Consolidated Financial Statements included in the Annual Report on Form
10
-K for the year ended
January 31, 2018.
 
Stock-Based Compensation
 
The following table sets forth reported stock-based compensation expense for the
three
and 
nine
months ended
October 31, 2018
and
2017:
 
   
Three Months Ended
October 31
,
   
Nine Months Ended
October 31
,
 
   
2018
   
2017
   
2018
   
2017
 
   
(in thousands)
   
(in thousands)
 
Cost of subscription
  $
65
    $
37
    $
182
    $
98
 
Cost of maintenance and other revenue
   
148
     
107
     
358
     
279
 
Cost of professional services
   
353
     
309
     
906
     
803
 
Sales and marketing
   
611
     
421
     
1,547
     
1,106
 
Research and development
   
442
     
338
     
1,170
     
895
 
General and administrative
   
529
     
1,099
     
3,455
     
3,490
 
Total stock-based compensation expense
  $
2,148
    $
2,311
    $
7,618
    $
6,671
 
 
 
RSU Information
 
The estimated fair value of RSUs was calculated based on the closing price of the Company’s common stock on the date of grant, reduced by the present value of dividends foregone during the vesting period.
 
The following table summarizes the activity for RSUs for the
nine
months ended
October 31, 2018: 
 
   
RSUs
   
Weighted
Average
Grant Date
Fair Value
 
   
(in thousands)
   
 
 
 
Outstanding at January 31, 2018
   
653
    $
25.10
 
Granted
   
276
     
52.75
 
Released
(1)
   
(262
)
   
25.82
 
Forfeited
   
(20
)
   
29.67
 
Outstanding at October 31, 2018
   
647
    $
36.47
 
_________________________
 
(
1
)
The number of RSUs released includes shares withheld on behalf of employees to satisfy the minimum statutory tax withholding requirements.
 
The Company withholds a portion of the released shares as consideration for the Company’s payment of applicable employee income taxes. During the
three
months ended
October 31, 2018,
the Company withheld
2,000
shares for payment of these taxes at a value of
$0.1
million. During the
nine
months ended
October 31, 2018,
the Company withheld
80,000
shares for payment of these taxes at a value of
$4.3
million.
  
Total unrecognized compensation cost related to RSUs was approximately
$20.4
million as of
October 31, 2018.
This cost is expected to be recognized over a weighted-average period of approximately
3.0
years. 
 
SAR Information
 
The weighted average assumptions used to value SARs granted in the
nine
months ended
October 31, 2018
and
2017
are shown in the following table:
 
   
Nine Months Ended
October 31
,
 
   
2018
   
2017
 
Expected life in years
(1)
   
5.50
     
5.50
 
Risk free interest rate
(2)
   
2.80
%
   
1.82
%
Volatility
(3)
   
31
%
   
33
%
Dividend rate
(4)
   
0.54
%
   
0.91
%
____________________________
(
1
)
The expected life of SARs granted under the stock-based compensation plans is based on historical vested SAR exercise and post-vest forfeiture patterns and includes an estimate of the expected term for SARs that were fully vested and outstanding.
 
(
2
)
The risk-free interest rate is based on the U.S. Treasury yield for a term consistent with the expected life of SARs in effect at the time of grant.
 
(
3
)
The Company estimates the volatility of its common stock at the date of grant based on the historical volatility of the Company’s common stock for a period equivalent to the expected life of the SARs, which it believes is representative of the expected volatility over the expected life of the SARs.
 
(
4
)
The Company expects to continue paying quarterly dividends at the same rate as the
nine
months ending on
October 31, 2018.
 
The following table summarizes the activity for outstanding SARs for the
nine
months ended
October 31, 2018:
 
   
SARs
(in thousands)
   
Weighted
Average
Exercise
Price per
Share
   
Weighted
Average
Remaining
Contractual
Term (years)
   
Aggregate
Intrinsic
Value
(in thousands)
 
Outstanding at January 31, 2018
   
3,024
    $
17.78
     
 
     
 
 
Granted
   
380
     
53.50
     
 
     
 
 
Exercised
   
(386
)
   
9.41
     
 
     
 
 
Expired
   
(5
)
   
8.97
     
 
     
 
 
Forfeited
   
(476
)
   
37.14
     
 
     
 
 
Outstanding at October 31, 2018
   
2,537
    $
20.80
     
3.8
    $
53,606
 
Vested and exercisable at October 31, 2018
   
2,062
    $
17.03
     
3.1
    $
49,271
 
 
The aggregate intrinsic value in the table above represents the total pretax intrinsic value (the aggregate difference between the closing stock price of the Company’s common stock based on the last trading day as of
October 31, 2018,
and the exercise price for in-the-money SARs) that would have been received by the holders if all SARs had been exercised on
October 31, 2018.
The total intrinsic value of SARs exercised in the
nine
months ended
October 31, 2018
was
$12.3
million. The weighted average grant date fair value per share of SARs granted in the
three
and
nine
months ended
October 31, 2018
was
$16.99
.
The weighted average grant date fair value per share of SARs granted in the
three
and
nine
months ended
October 31, 2017
was
$9.59
.
 
The number of SARs exercised includes shares withheld on behalf of employees to satisfy minimum statutory tax withholding requirements.  During the
three
months ended
October 31, 2018,
the Company withheld
700
shares for payment of these taxes at a value of
$44,000.
During the
nine
months ended
October 31, 2018,
the Company withheld
103,000
shares for payment of these taxes at a value of
$4.4
million.
 
At
October 31, 2018,
there was approximately
$4.8
million of total unrecognized compensation cost related to unvested SARs. This cost is expected to be recognized over a weighted-average period of approximately
3.0
years.